Literature DB >> 19172207

Do patients undergo prostate examination while having a colonoscopy?

Tess Hammett1, Lawrence C Hookey, Jun Kawakami.   

Abstract

OBJECTIVES: To determine the rate at which physicians report performing a digital rectal examination and comment on the prostate gland before performing colonoscopy in men 50 to 70 years of age.
METHODS: A retrospective chart review of all men 50 to 70 years of age who had a colonoscopy in Kingston, Ontario, in 2005 was completed. It was noted whether each physician described performing a digital rectal examination before the colonoscopy, and if so, whether he or she commented on the prostate.
RESULTS: In 2005, 846 eligible colonoscopies were performed by 17 physicians in Kingston, Ontario. In 29.2% of cases, the physician made no comment about having performed a digital rectal examination; in 55.8% of cases, the physician commented on having completed a digital rectal examination but said nothing about the prostate; and in 15.0% of cases, the physician made a comment regarding the prostate. No physician consistently commented on the prostate for all patients, and in no circumstances was direct referral to another physician or follow-up suggested. DISCUSSION: A colonoscopy presents an ideal opportunity for physicians to use a digital rectal examination to assess for prostate cancer. Physicians performing colonoscopies in men 50 to 70 years of age should pay special attention to the prostate while performing a digital rectal examination before colonoscopy. This novel concept may help maximize resources for cancer screening and could potentially increase the detection rate of clinically palpable prostate cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19172207      PMCID: PMC2695146          DOI: 10.1155/2009/721870

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  13 in total

1.  Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma.

Authors:  Kishor Mistry; Greg Cable
Journal:  J Am Board Fam Pract       Date:  2003 Mar-Apr

2.  Screening for prostate cancer: recommendation and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

3.  Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.

Authors:  R E Tarone; K C Chu; O W Brawley
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

Review 4.  Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Authors:  Fritz H Schröder
Journal:  Can J Urol       Date:  2005-02       Impact factor: 1.344

5.  Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Authors:  F H Schröder; P van der Maas; P Beemsterboer; A B Kruger; R Hoedemaeker; J Rietbergen; R Kranse
Journal:  J Natl Cancer Inst       Date:  1998-12-02       Impact factor: 13.506

6.  Increased cumulative incidence of prostate malignancies in colorectal cancer patients.

Authors:  Nuri Ozden; Murat Saruc; Lynette M Smith; Arthi Sanjeevi; Hemant K Roy
Journal:  Int J Gastrointest Cancer       Date:  2003

7.  The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.

Authors:  Gerald L Andriole; Douglas Reding; Richard B Hayes; Philip C Prorok; John K Gohagan
Journal:  Urol Oncol       Date:  2004 Jul-Aug       Impact factor: 3.498

8.  Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.

Authors:  Louis Potters; Eric A Klein; Michael W Kattan; Chandana A Reddy; Jay P Ciezki; Alwyn M Reuther; Patrick A Kupelian
Journal:  Radiother Oncol       Date:  2004-04       Impact factor: 6.280

9.  Colonoscopy effects on serum prostate specific antigen levels.

Authors:  C Barbatzas; A Dellis; I Grivas; N Trakas; A Ekonomou; A Kostakopoulos
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

10.  Lead time associated with screening for prostate cancer.

Authors:  Magnus Törnblom; Henry Eriksson; Stefan Franzén; Ove Gustafsson; Hans Lilja; Ulf Norming; Jonas Hugosson
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.